ICD1882K ;ALB/JDG - YEARLY DRG UPDATE;8/1/2015
 ;;18.0;DRG Grouper;**82**;Oct 20, 2000;Build 21
 ;
 ; Updates for DRGS 810-999
 Q
 ;
MSDRG ;;MS-DRG^MDC^TYPE^MS-DRG TITLE^WEIGHTS^GEOMETRIC MEAN LOS
 ;;810^16^MED^MAJOR HEMATOL/IMMUN DIAG EXC SICKLE CELL CRISIS & COAGUL W/O CC/MCC^.8644^2.7
 ;;811^16^MED^RED BLOOD CELL DISORDERS W MCC^1.2992^3.7
 ;;812^16^MED^RED BLOOD CELL DISORDERS W/O MCC^.8572^2.8
 ;;813^16^MED^COAGULATION DISORDERS^1.7350^3.7
 ;;814^16^MED^RETICULOENDOTHELIAL & IMMUNITY DISORDERS W MCC^1.6622^4.7
 ;;815^16^MED^RETICULOENDOTHELIAL & IMMUNITY DISORDERS W CC^.9803^3.2
 ;;816^16^MED^RETICULOENDOTHELIAL & IMMUNITY DISORDERS W/O CC/MCC^.6962^2.4
 ;;820^17^SURG^LYMPHOMA & LEUKEMIA W MAJOR O.R. PROCEDURE W MCC^5.9153^12.1
 ;;821^17^SURG^LYMPHOMA & LEUKEMIA W MAJOR O.R. PROCEDURE W CC^2.3113^4.7
 ;;822^17^SURG^LYMPHOMA & LEUKEMIA W MAJOR O.R. PROCEDURE W/O CC/MCC^1.2851^2.1
 ;;823^17^SURG^LYMPHOMA & NON-ACUTE LEUKEMIA W OTHER O.R. PROC W MCC^4.4536^11.1
 ;;824^17^SURG^LYMPHOMA & NON-ACUTE LEUKEMIA W OTHER O.R. PROC W CC^2.3467^6.0
 ;;825^17^SURG^LYMPHOMA & NON-ACUTE LEUKEMIA W OTHER O.R. PROC W/O CC/MCC^1.3967^2.9
 ;;826^17^SURG^MYELOPROLIF DISORD OR POORLY DIFF NEOPL W MAJ O.R. PROC W MCC^5.1814^10.8
 ;;827^17^SURG^MYELOPROLIF DISORD OR POORLY DIFF NEOPL W MAJ O.R. PROC W CC^2.3141^5.0
 ;;828^17^SURG^MYELOPROLIF DISORD OR POORLY DIFF NEOPL W MAJ O.R. PROC W/O CC/MCC^1.5139^2.8
 ;;829^17^SURG^MYELOPROLIF DISORD OR POORLY DIFF NEOPL W OTHER O.R. PROC W CC/MCC^3.3241^6.8
 ;;830^17^SURG^MYELOPROLIF DISORD OR POORLY DIFF NEOPL W OTHER O.R. PROC W/O CC/MCC^1.3670^2.6
 ;;834^17^MED^ACUTE LEUKEMIA W/O MAJOR O.R. PROCEDURE W MCC^5.5990^10.4
 ;;835^17^MED^ACUTE LEUKEMIA W/O MAJOR O.R. PROCEDURE W CC^2.3024^4.9
 ;;836^17^MED^ACUTE LEUKEMIA W/O MAJOR O.R. PROCEDURE W/O CC/MCC^1.1381^2.9
 ;;837^17^MED^CHEMO W ACUTE LEUKEMIA AS SDX OR W HIGH DOSE CHEMO AGENT W MCC^6.1348^15.7
 ;;838^17^MED^CHEMO W ACUTE LEUKEMIA AS SDX W CC OR HIGH DOSE CHEMO AGENT^2.7707^7.0
 ;;839^17^MED^CHEMO W ACUTE LEUKEMIA AS SDX W/O CC/MCC^1.3190^4.9
 ;;840^17^MED^LYMPHOMA & NON-ACUTE LEUKEMIA W MCC^3.1449^7.6
 ;;841^17^MED^LYMPHOMA & NON-ACUTE LEUKEMIA W CC^1.6118^4.7
 ;;842^17^MED^LYMPHOMA & NON-ACUTE LEUKEMIA W/O CC/MCC^1.1167^3.1
 ;;843^17^MED^OTHER MYELOPROLIF DIS OR POORLY DIFF NEOPL DIAG W MCC^1.8464^5.6
 ;;844^17^MED^OTHER MYELOPROLIF DIS OR POORLY DIFF NEOPL DIAG W CC^1.1233^4.0
 ;;845^17^MED^OTHER MYELOPROLIF DIS OR POORLY DIFF NEOPL DIAG W/O CC/MCC^.8261^2.8
 ;;846^17^MED^CHEMOTHERAPY W/O ACUTE LEUKEMIA AS SECONDARY DIAGNOSIS W MCC^2.4618^5.9
 ;;847^17^MED^CHEMOTHERAPY W/O ACUTE LEUKEMIA AS SECONDARY DIAGNOSIS W CC^1.1883^3.4
 ;;848^17^MED^CHEMOTHERAPY W/O ACUTE LEUKEMIA AS SECONDARY DIAGNOSIS W/O CC/MCC^.9352^2.8
 ;;849^17^MED^RADIOTHERAPY^1.6745^4.9
 ;;853^18^SURG^INFECTIOUS & PARASITIC DISEASES W O.R. PROCEDURE W MCC^5.1334^10.7
 ;;854^18^SURG^INFECTIOUS & PARASITIC DISEASES W O.R. PROCEDURE W CC^2.3804^6.6
 ;;855^18^SURG^INFECTIOUS & PARASITIC DISEASES W O.R. PROCEDURE W/O CC/MCC^1.5124^3.5
 ;;856^18^SURG^POSTOPERATIVE OR POST-TRAUMATIC INFECTIONS W O.R. PROC W MCC^4.6569^9.8
 ;;857^18^SURG^POSTOPERATIVE OR POST-TRAUMATIC INFECTIONS W O.R. PROC W CC^2.0516^5.6
 ;;858^18^SURG^POSTOPERATIVE OR POST-TRAUMATIC INFECTIONS W O.R. PROC W/O CC/MCC^1.3300^3.8
 ;;862^18^MED^POSTOPERATIVE & POST-TRAUMATIC INFECTIONS W MCC^1.8550^5.5
 ;;863^18^MED^POSTOPERATIVE & POST-TRAUMATIC INFECTIONS W/O MCC^1.0089^3.7
 ;;864^18^MED^FEVER^.8481^2.8
 ;;865^18^MED^VIRAL ILLNESS W MCC^1.5273^4.2
 ;;866^18^MED^VIRAL ILLNESS W/O MCC^.7739^2.8
 ;;867^18^MED^OTHER INFECTIOUS & PARASITIC DISEASES DIAGNOSES W MCC^2.6068^6.7
 ;;868^18^MED^OTHER INFECTIOUS & PARASITIC DISEASES DIAGNOSES W CC^1.0292^3.8
 ;;869^18^MED^OTHER INFECTIOUS & PARASITIC DISEASES DIAGNOSES W/O CC/MCC^.7091^2.8
 ;;870^18^MED^SEPTICEMIA OR SEVERE SEPSIS W MV >96 HOURS^5.8782^12.6
 ;;871^18^MED^SEPTICEMIA OR SEVERE SEPSIS W/O MV >96 HOURS W MCC^1.7926^5.0
 ;;872^18^MED^SEPTICEMIA OR SEVERE SEPSIS W/O MV >96 HOURS W/O MCC^1.0427^3.9
 ;;876^19^SURG^O.R. PROCEDURE W PRINCIPAL DIAGNOSES OF MENTAL ILLNESS^3.0841^7.8
 ;;880^19^MED^ACUTE ADJUSTMENT REACTION & PSYCHOSOCIAL DYSFUNCTION^.7227^2.4
 ;;881^19^MED^DEPRESSIVE NEUROSES^.6618^3.4
 ;;882^19^MED^NEUROSES EXCEPT DEPRESSIVE^.6924^3.3
 ;;883^19^MED^DISORDERS OF PERSONALITY & IMPULSE CONTROL^1.3737^4.6
 ;;884^19^MED^ORGANIC DISTURBANCES & MENTAL RETARDATION^1.1483^4.3
 ;;885^19^MED^PSYCHOSES^1.0575^5.6
 ;;886^19^MED^BEHAVIORAL & DEVELOPMENTAL DISORDERS^.8718^3.9
 ;;887^19^MED^OTHER MENTAL DISORDER DIAGNOSES^.9939^3.0
 ;;894^20^MED^ALCOHOL/DRUG ABUSE OR DEPENDENCE, LEFT AMA^.4859^2.1
 ;;895^20^MED^ALCOHOL/DRUG ABUSE OR DEPENDENCE W REHABILITATION THERAPY^1.2435^9.3
 ;;896^20^MED^ALCOHOL/DRUG ABUSE OR DEPENDENCE W/O REHABILITATION THERAPY W MCC^1.5678^4.8
 ;;897^20^MED^ALCOHOL/DRUG ABUSE OR DEPENDENCE W/O REHABILITATION THERAPY W/O MCC^.7231^3.3
 ;;901^21^SURG^WOUND DEBRIDEMENTS FOR INJURIES W MCC^3.9370^9.2
 ;;902^21^SURG^WOUND DEBRIDEMENTS FOR INJURIES W CC^1.8265^5.3
 ;;903^21^SURG^WOUND DEBRIDEMENTS FOR INJURIES W/O CC/MCC^1.1723^3.3
 ;;904^21^SURG^SKIN GRAFTS FOR INJURIES W CC/MCC^3.2140^7.1
 ;;905^21^SURG^SKIN GRAFTS FOR INJURIES W/O CC/MCC^1.4233^3.6
 ;;906^21^SURG^HAND PROCEDURES FOR INJURIES^1.5670^2.8
 ;;907^21^SURG^OTHER O.R. PROCEDURES FOR INJURIES W MCC^3.8073^7.5
 ;;908^21^SURG^OTHER O.R. PROCEDURES FOR INJURIES W CC^1.9904^4.3
 ;;909^21^SURG^OTHER O.R. PROCEDURES FOR INJURIES W/O CC/MCC^1.2992^2.6
 ;;913^21^MED^TRAUMATIC INJURY W MCC^1.3561^3.8
 ;;914^21^MED^TRAUMATIC INJURY W/O MCC^.7317^2.5
 ;;915^21^MED^ALLERGIC REACTIONS W MCC^1.6040^3.7
 ;;916^21^MED^ALLERGIC REACTIONS W/O MCC^.5582^1.8
 ;;917^21^MED^POISONING & TOXIC EFFECTS OF DRUGS W MCC^1.4065^3.5
 ;;918^21^MED^POISONING & TOXIC EFFECTS OF DRUGS W/O MCC^.6859^2.2
 ;;919^21^MED^COMPLICATIONS OF TREATMENT W MCC^1.7611^4.5
 ;;920^21^MED^COMPLICATIONS OF TREATMENT W CC^.9991^3.1
 ;;921^21^MED^COMPLICATIONS OF TREATMENT W/O CC/MCC^.6960^2.3
 ;;922^21^MED^OTHER INJURY, POISONING & TOXIC EFFECT DIAG W MCC^1.5833^4.0
 ;;923^21^MED^OTHER INJURY, POISONING & TOXIC EFFECT DIAG W/O MCC^.8117^2.5
 ;;927^22^SURG^EXTENSIVE BURNS OR FULL THICKNESS BURNS W MV >96 HRS W SKIN GRAFT^15.9672^23.5
 ;;928^22^SURG^FULL THICKNESS BURN W SKIN GRAFT OR INHAL INJ W CC/MCC^5.7399^11.3
 ;;929^22^SURG^FULL THICKNESS BURN W SKIN GRAFT OR INHAL INJ W/O CC/MCC^2.4661^5.5
 ;;933^22^MED^EXTENSIVE BURNS OR FULL THICKNESS BURNS W MV >96 HRS W/O SKIN GRAFT^2.8685^2.6
 ;;934^22^MED^FULL THICKNESS BURN W/O SKIN GRFT OR INHAL INJ^1.6716^4.2
 ;;935^22^MED^NON-EXTENSIVE BURNS^1.5141^3.4
 ;;939^23^SURG^O.R. PROC W DIAGNOSES OF OTHER CONTACT W HEALTH SERVICES W MCC^2.9866^6.2
 ;;940^23^SURG^O.R. PROC W DIAGNOSES OF OTHER CONTACT W HEALTH SERVICES W CC^1.9107^3.7
 ;;941^23^SURG^O.R. PROC W DIAGNOSES OF OTHER CONTACT W HEALTH SERVICES W/O CC/MCC^1.3589^2.1
 ;;945^23^MED^REHABILITATION W CC/MCC^1.2781^8.8
 ;;946^23^MED^REHABILITATION W/O CC/MCC^1.0151^6.8
 ;;947^23^MED^SIGNS & SYMPTOMS W MCC^1.1323^3.5
 ;;948^23^MED^SIGNS & SYMPTOMS W/O MCC^.7356^2.7
 ;;949^23^MED^AFTERCARE W CC/MCC^1.1197^3.3
 ;;950^23^MED^AFTERCARE W/O CC/MCC^.5798^2.3
 ;;951^23^MED^OTHER FACTORS INFLUENCING HEALTH STATUS^.9885^2.7
 ;;955^24^SURG^CRANIOTOMY FOR MULTIPLE SIGNIFICANT TRAUMA^5.6773^8.4
 ;;956^24^SURG^LIMB REATTACHMENT, HIP & FEMUR PROC FOR MULTIPLE SIGNIFICANT TRAUMA^3.7116^6.4
 ;;957^24^SURG^OTHER O.R. PROCEDURES FOR MULTIPLE SIGNIFICANT TRAUMA W MCC^6.5504^9.4
 ;;958^24^SURG^OTHER O.R. PROCEDURES FOR MULTIPLE SIGNIFICANT TRAUMA W CC^3.8565^6.9
 ;;959^24^SURG^OTHER O.R. PROCEDURES FOR MULTIPLE SIGNIFICANT TRAUMA W/O CC/MCC^2.1705^4.2
 ;;963^24^MED^OTHER MULTIPLE SIGNIFICANT TRAUMA W MCC^2.6295^5.4
 ;;964^24^MED^OTHER MULTIPLE SIGNIFICANT TRAUMA W CC^1.4205^4.1
 ;;965^24^MED^OTHER MULTIPLE SIGNIFICANT TRAUMA W/O CC/MCC^.9217^3.0
 ;;969^25^SURG^HIV W EXTENSIVE O.R. PROCEDURE W MCC^5.0291^11.2
 ;;970^25^SURG^HIV W EXTENSIVE O.R. PROCEDURE W/O MCC^2.7871^5.1
 ;;974^25^MED^HIV W MAJOR RELATED CONDITION W MCC^2.6531^6.6
 ;;975^25^MED^HIV W MAJOR RELATED CONDITION W CC^1.3589^4.5
 ;;976^25^MED^HIV W MAJOR RELATED CONDITION W/O CC/MCC^.9073^3.3
 ;;977^25^MED^HIV W OR W/O OTHER RELATED CONDITION^1.1577^3.5
 ;;981^99^SURG^EXTENSIVE O.R. PROCEDURE UNRELATED TO PRINCIPAL DIAGNOSIS W MCC^4.8532^9.5
 ;;982^99^SURG^EXTENSIVE O.R. PROCEDURE UNRELATED TO PRINCIPAL DIAGNOSIS W CC^2.7416^5.4
 ;;983^99^SURG^EXTENSIVE O.R. PROCEDURE UNRELATED TO PRINCIPAL DIAGNOSIS W/O CC/MCC^1.7615^2.8
 ;;984^99^SURG^PROSTATIC O.R. PROCEDURE UNRELATED TO PRINCIPAL DIAGNOSIS W MCC^3.3844^9.3
 ;;985^99^SURG^PROSTATIC O.R. PROCEDURE UNRELATED TO PRINCIPAL DIAGNOSIS W CC^1.9339^4.8
 ;;986^99^SURG^PROSTATIC O.R. PROCEDURE UNRELATED TO PRINCIPAL DIAGNOSIS W/O CC/MCC^1.2079^2.4
 ;;987^99^SURG^NON-EXTENSIVE O.R. PROC UNRELATED TO PRINCIPAL DIAGNOSIS W MCC^3.2123^8.0
 ;;988^99^SURG^NON-EXTENSIVE O.R. PROC UNRELATED TO PRINCIPAL DIAGNOSIS W CC^1.7533^4.6
 ;;989^99^SURG^NON-EXTENSIVE O.R. PROC UNRELATED TO PRINCIPAL DIAGNOSIS W/O CC/MCC^1.0425^2.2
 ;;998^99^**^PRINCIPAL DIAGNOSIS INVALID AS DISCHARGE DIAGNOSIS^0.0000^0.0000
 ;;999^99^**^UNGROUPABLE^0.0000^0.0000
 ;;EXIT
 
--- Routine Detail   --- with STRUCTURED ROUTINE LISTING ---[H[J[2J[HICD1882K   9304     printed  Sep 23, 2025@19:25:19                                                                                                                                                                                                    Page 2
ICD1882K  ;ALB/JDG - YEARLY DRG UPDATE;8/1/2015
 +1       ;;18.0;DRG Grouper;**82**;Oct 20, 2000;Build 21
 +2       ;
 +3       ; Updates for DRGS 810-999
 +4        QUIT 
 +5       ;
MSDRG     ;;MS-DRG^MDC^TYPE^MS-DRG TITLE^WEIGHTS^GEOMETRIC MEAN LOS
 +1       ;;810^16^MED^MAJOR HEMATOL/IMMUN DIAG EXC SICKLE CELL CRISIS & COAGUL W/O CC/MCC^.8644^2.7
 +2       ;;811^16^MED^RED BLOOD CELL DISORDERS W MCC^1.2992^3.7
 +3       ;;812^16^MED^RED BLOOD CELL DISORDERS W/O MCC^.8572^2.8
 +4       ;;813^16^MED^COAGULATION DISORDERS^1.7350^3.7
 +5       ;;814^16^MED^RETICULOENDOTHELIAL & IMMUNITY DISORDERS W MCC^1.6622^4.7
 +6       ;;815^16^MED^RETICULOENDOTHELIAL & IMMUNITY DISORDERS W CC^.9803^3.2
 +7       ;;816^16^MED^RETICULOENDOTHELIAL & IMMUNITY DISORDERS W/O CC/MCC^.6962^2.4
 +8       ;;820^17^SURG^LYMPHOMA & LEUKEMIA W MAJOR O.R. PROCEDURE W MCC^5.9153^12.1
 +9       ;;821^17^SURG^LYMPHOMA & LEUKEMIA W MAJOR O.R. PROCEDURE W CC^2.3113^4.7
 +10      ;;822^17^SURG^LYMPHOMA & LEUKEMIA W MAJOR O.R. PROCEDURE W/O CC/MCC^1.2851^2.1
 +11      ;;823^17^SURG^LYMPHOMA & NON-ACUTE LEUKEMIA W OTHER O.R. PROC W MCC^4.4536^11.1
 +12      ;;824^17^SURG^LYMPHOMA & NON-ACUTE LEUKEMIA W OTHER O.R. PROC W CC^2.3467^6.0
 +13      ;;825^17^SURG^LYMPHOMA & NON-ACUTE LEUKEMIA W OTHER O.R. PROC W/O CC/MCC^1.3967^2.9
 +14      ;;826^17^SURG^MYELOPROLIF DISORD OR POORLY DIFF NEOPL W MAJ O.R. PROC W MCC^5.1814^10.8
 +15      ;;827^17^SURG^MYELOPROLIF DISORD OR POORLY DIFF NEOPL W MAJ O.R. PROC W CC^2.3141^5.0
 +16      ;;828^17^SURG^MYELOPROLIF DISORD OR POORLY DIFF NEOPL W MAJ O.R. PROC W/O CC/MCC^1.5139^2.8
 +17      ;;829^17^SURG^MYELOPROLIF DISORD OR POORLY DIFF NEOPL W OTHER O.R. PROC W CC/MCC^3.3241^6.8
 +18      ;;830^17^SURG^MYELOPROLIF DISORD OR POORLY DIFF NEOPL W OTHER O.R. PROC W/O CC/MCC^1.3670^2.6
 +19      ;;834^17^MED^ACUTE LEUKEMIA W/O MAJOR O.R. PROCEDURE W MCC^5.5990^10.4
 +20      ;;835^17^MED^ACUTE LEUKEMIA W/O MAJOR O.R. PROCEDURE W CC^2.3024^4.9
 +21      ;;836^17^MED^ACUTE LEUKEMIA W/O MAJOR O.R. PROCEDURE W/O CC/MCC^1.1381^2.9
 +22      ;;837^17^MED^CHEMO W ACUTE LEUKEMIA AS SDX OR W HIGH DOSE CHEMO AGENT W MCC^6.1348^15.7
 +23      ;;838^17^MED^CHEMO W ACUTE LEUKEMIA AS SDX W CC OR HIGH DOSE CHEMO AGENT^2.7707^7.0
 +24      ;;839^17^MED^CHEMO W ACUTE LEUKEMIA AS SDX W/O CC/MCC^1.3190^4.9
 +25      ;;840^17^MED^LYMPHOMA & NON-ACUTE LEUKEMIA W MCC^3.1449^7.6
 +26      ;;841^17^MED^LYMPHOMA & NON-ACUTE LEUKEMIA W CC^1.6118^4.7
 +27      ;;842^17^MED^LYMPHOMA & NON-ACUTE LEUKEMIA W/O CC/MCC^1.1167^3.1
 +28      ;;843^17^MED^OTHER MYELOPROLIF DIS OR POORLY DIFF NEOPL DIAG W MCC^1.8464^5.6
 +29      ;;844^17^MED^OTHER MYELOPROLIF DIS OR POORLY DIFF NEOPL DIAG W CC^1.1233^4.0
 +30      ;;845^17^MED^OTHER MYELOPROLIF DIS OR POORLY DIFF NEOPL DIAG W/O CC/MCC^.8261^2.8
 +31      ;;846^17^MED^CHEMOTHERAPY W/O ACUTE LEUKEMIA AS SECONDARY DIAGNOSIS W MCC^2.4618^5.9
 +32      ;;847^17^MED^CHEMOTHERAPY W/O ACUTE LEUKEMIA AS SECONDARY DIAGNOSIS W CC^1.1883^3.4
 +33      ;;848^17^MED^CHEMOTHERAPY W/O ACUTE LEUKEMIA AS SECONDARY DIAGNOSIS W/O CC/MCC^.9352^2.8
 +34      ;;849^17^MED^RADIOTHERAPY^1.6745^4.9
 +35      ;;853^18^SURG^INFECTIOUS & PARASITIC DISEASES W O.R. PROCEDURE W MCC^5.1334^10.7
 +36      ;;854^18^SURG^INFECTIOUS & PARASITIC DISEASES W O.R. PROCEDURE W CC^2.3804^6.6
 +37      ;;855^18^SURG^INFECTIOUS & PARASITIC DISEASES W O.R. PROCEDURE W/O CC/MCC^1.5124^3.5
 +38      ;;856^18^SURG^POSTOPERATIVE OR POST-TRAUMATIC INFECTIONS W O.R. PROC W MCC^4.6569^9.8
 +39      ;;857^18^SURG^POSTOPERATIVE OR POST-TRAUMATIC INFECTIONS W O.R. PROC W CC^2.0516^5.6
 +40      ;;858^18^SURG^POSTOPERATIVE OR POST-TRAUMATIC INFECTIONS W O.R. PROC W/O CC/MCC^1.3300^3.8
 +41      ;;862^18^MED^POSTOPERATIVE & POST-TRAUMATIC INFECTIONS W MCC^1.8550^5.5
 +42      ;;863^18^MED^POSTOPERATIVE & POST-TRAUMATIC INFECTIONS W/O MCC^1.0089^3.7
 +43      ;;864^18^MED^FEVER^.8481^2.8
 +44      ;;865^18^MED^VIRAL ILLNESS W MCC^1.5273^4.2
 +45      ;;866^18^MED^VIRAL ILLNESS W/O MCC^.7739^2.8
 +46      ;;867^18^MED^OTHER INFECTIOUS & PARASITIC DISEASES DIAGNOSES W MCC^2.6068^6.7
 +47      ;;868^18^MED^OTHER INFECTIOUS & PARASITIC DISEASES DIAGNOSES W CC^1.0292^3.8
 +48      ;;869^18^MED^OTHER INFECTIOUS & PARASITIC DISEASES DIAGNOSES W/O CC/MCC^.7091^2.8
 +49      ;;870^18^MED^SEPTICEMIA OR SEVERE SEPSIS W MV >96 HOURS^5.8782^12.6
 +50      ;;871^18^MED^SEPTICEMIA OR SEVERE SEPSIS W/O MV >96 HOURS W MCC^1.7926^5.0
 +51      ;;872^18^MED^SEPTICEMIA OR SEVERE SEPSIS W/O MV >96 HOURS W/O MCC^1.0427^3.9
 +52      ;;876^19^SURG^O.R. PROCEDURE W PRINCIPAL DIAGNOSES OF MENTAL ILLNESS^3.0841^7.8
 +53      ;;880^19^MED^ACUTE ADJUSTMENT REACTION & PSYCHOSOCIAL DYSFUNCTION^.7227^2.4
 +54      ;;881^19^MED^DEPRESSIVE NEUROSES^.6618^3.4
 +55      ;;882^19^MED^NEUROSES EXCEPT DEPRESSIVE^.6924^3.3
 +56      ;;883^19^MED^DISORDERS OF PERSONALITY & IMPULSE CONTROL^1.3737^4.6
 +57      ;;884^19^MED^ORGANIC DISTURBANCES & MENTAL RETARDATION^1.1483^4.3
 +58      ;;885^19^MED^PSYCHOSES^1.0575^5.6
 +59      ;;886^19^MED^BEHAVIORAL & DEVELOPMENTAL DISORDERS^.8718^3.9
 +60      ;;887^19^MED^OTHER MENTAL DISORDER DIAGNOSES^.9939^3.0
 +61      ;;894^20^MED^ALCOHOL/DRUG ABUSE OR DEPENDENCE, LEFT AMA^.4859^2.1
 +62      ;;895^20^MED^ALCOHOL/DRUG ABUSE OR DEPENDENCE W REHABILITATION THERAPY^1.2435^9.3
 +63      ;;896^20^MED^ALCOHOL/DRUG ABUSE OR DEPENDENCE W/O REHABILITATION THERAPY W MCC^1.5678^4.8
 +64      ;;897^20^MED^ALCOHOL/DRUG ABUSE OR DEPENDENCE W/O REHABILITATION THERAPY W/O MCC^.7231^3.3
 +65      ;;901^21^SURG^WOUND DEBRIDEMENTS FOR INJURIES W MCC^3.9370^9.2
 +66      ;;902^21^SURG^WOUND DEBRIDEMENTS FOR INJURIES W CC^1.8265^5.3
 +67      ;;903^21^SURG^WOUND DEBRIDEMENTS FOR INJURIES W/O CC/MCC^1.1723^3.3
 +68      ;;904^21^SURG^SKIN GRAFTS FOR INJURIES W CC/MCC^3.2140^7.1
 +69      ;;905^21^SURG^SKIN GRAFTS FOR INJURIES W/O CC/MCC^1.4233^3.6
 +70      ;;906^21^SURG^HAND PROCEDURES FOR INJURIES^1.5670^2.8
 +71      ;;907^21^SURG^OTHER O.R. PROCEDURES FOR INJURIES W MCC^3.8073^7.5
 +72      ;;908^21^SURG^OTHER O.R. PROCEDURES FOR INJURIES W CC^1.9904^4.3
 +73      ;;909^21^SURG^OTHER O.R. PROCEDURES FOR INJURIES W/O CC/MCC^1.2992^2.6
 +74      ;;913^21^MED^TRAUMATIC INJURY W MCC^1.3561^3.8
 +75      ;;914^21^MED^TRAUMATIC INJURY W/O MCC^.7317^2.5
 +76      ;;915^21^MED^ALLERGIC REACTIONS W MCC^1.6040^3.7
 +77      ;;916^21^MED^ALLERGIC REACTIONS W/O MCC^.5582^1.8
 +78      ;;917^21^MED^POISONING & TOXIC EFFECTS OF DRUGS W MCC^1.4065^3.5
 +79      ;;918^21^MED^POISONING & TOXIC EFFECTS OF DRUGS W/O MCC^.6859^2.2
 +80      ;;919^21^MED^COMPLICATIONS OF TREATMENT W MCC^1.7611^4.5
 +81      ;;920^21^MED^COMPLICATIONS OF TREATMENT W CC^.9991^3.1
 +82      ;;921^21^MED^COMPLICATIONS OF TREATMENT W/O CC/MCC^.6960^2.3
 +83      ;;922^21^MED^OTHER INJURY, POISONING & TOXIC EFFECT DIAG W MCC^1.5833^4.0
 +84      ;;923^21^MED^OTHER INJURY, POISONING & TOXIC EFFECT DIAG W/O MCC^.8117^2.5
 +85      ;;927^22^SURG^EXTENSIVE BURNS OR FULL THICKNESS BURNS W MV >96 HRS W SKIN GRAFT^15.9672^23.5
 +86      ;;928^22^SURG^FULL THICKNESS BURN W SKIN GRAFT OR INHAL INJ W CC/MCC^5.7399^11.3
 +87      ;;929^22^SURG^FULL THICKNESS BURN W SKIN GRAFT OR INHAL INJ W/O CC/MCC^2.4661^5.5
 +88      ;;933^22^MED^EXTENSIVE BURNS OR FULL THICKNESS BURNS W MV >96 HRS W/O SKIN GRAFT^2.8685^2.6
 +89      ;;934^22^MED^FULL THICKNESS BURN W/O SKIN GRFT OR INHAL INJ^1.6716^4.2
 +90      ;;935^22^MED^NON-EXTENSIVE BURNS^1.5141^3.4
 +91      ;;939^23^SURG^O.R. PROC W DIAGNOSES OF OTHER CONTACT W HEALTH SERVICES W MCC^2.9866^6.2
 +92      ;;940^23^SURG^O.R. PROC W DIAGNOSES OF OTHER CONTACT W HEALTH SERVICES W CC^1.9107^3.7
 +93      ;;941^23^SURG^O.R. PROC W DIAGNOSES OF OTHER CONTACT W HEALTH SERVICES W/O CC/MCC^1.3589^2.1
 +94      ;;945^23^MED^REHABILITATION W CC/MCC^1.2781^8.8
 +95      ;;946^23^MED^REHABILITATION W/O CC/MCC^1.0151^6.8
 +96      ;;947^23^MED^SIGNS & SYMPTOMS W MCC^1.1323^3.5
 +97      ;;948^23^MED^SIGNS & SYMPTOMS W/O MCC^.7356^2.7
 +98      ;;949^23^MED^AFTERCARE W CC/MCC^1.1197^3.3
 +99      ;;950^23^MED^AFTERCARE W/O CC/MCC^.5798^2.3
 +100     ;;951^23^MED^OTHER FACTORS INFLUENCING HEALTH STATUS^.9885^2.7
 +101     ;;955^24^SURG^CRANIOTOMY FOR MULTIPLE SIGNIFICANT TRAUMA^5.6773^8.4
 +102     ;;956^24^SURG^LIMB REATTACHMENT, HIP & FEMUR PROC FOR MULTIPLE SIGNIFICANT TRAUMA^3.7116^6.4
 +103     ;;957^24^SURG^OTHER O.R. PROCEDURES FOR MULTIPLE SIGNIFICANT TRAUMA W MCC^6.5504^9.4
 +104     ;;958^24^SURG^OTHER O.R. PROCEDURES FOR MULTIPLE SIGNIFICANT TRAUMA W CC^3.8565^6.9
 +105     ;;959^24^SURG^OTHER O.R. PROCEDURES FOR MULTIPLE SIGNIFICANT TRAUMA W/O CC/MCC^2.1705^4.2
 +106     ;;963^24^MED^OTHER MULTIPLE SIGNIFICANT TRAUMA W MCC^2.6295^5.4
 +107     ;;964^24^MED^OTHER MULTIPLE SIGNIFICANT TRAUMA W CC^1.4205^4.1
 +108     ;;965^24^MED^OTHER MULTIPLE SIGNIFICANT TRAUMA W/O CC/MCC^.9217^3.0
 +109     ;;969^25^SURG^HIV W EXTENSIVE O.R. PROCEDURE W MCC^5.0291^11.2
 +110     ;;970^25^SURG^HIV W EXTENSIVE O.R. PROCEDURE W/O MCC^2.7871^5.1
 +111     ;;974^25^MED^HIV W MAJOR RELATED CONDITION W MCC^2.6531^6.6
 +112     ;;975^25^MED^HIV W MAJOR RELATED CONDITION W CC^1.3589^4.5
 +113     ;;976^25^MED^HIV W MAJOR RELATED CONDITION W/O CC/MCC^.9073^3.3
 +114     ;;977^25^MED^HIV W OR W/O OTHER RELATED CONDITION^1.1577^3.5
 +115     ;;981^99^SURG^EXTENSIVE O.R. PROCEDURE UNRELATED TO PRINCIPAL DIAGNOSIS W MCC^4.8532^9.5
 +116     ;;982^99^SURG^EXTENSIVE O.R. PROCEDURE UNRELATED TO PRINCIPAL DIAGNOSIS W CC^2.7416^5.4
 +117     ;;983^99^SURG^EXTENSIVE O.R. PROCEDURE UNRELATED TO PRINCIPAL DIAGNOSIS W/O CC/MCC^1.7615^2.8
 +118     ;;984^99^SURG^PROSTATIC O.R. PROCEDURE UNRELATED TO PRINCIPAL DIAGNOSIS W MCC^3.3844^9.3
 +119     ;;985^99^SURG^PROSTATIC O.R. PROCEDURE UNRELATED TO PRINCIPAL DIAGNOSIS W CC^1.9339^4.8
 +120     ;;986^99^SURG^PROSTATIC O.R. PROCEDURE UNRELATED TO PRINCIPAL DIAGNOSIS W/O CC/MCC^1.2079^2.4
 +121     ;;987^99^SURG^NON-EXTENSIVE O.R. PROC UNRELATED TO PRINCIPAL DIAGNOSIS W MCC^3.2123^8.0
 +122     ;;988^99^SURG^NON-EXTENSIVE O.R. PROC UNRELATED TO PRINCIPAL DIAGNOSIS W CC^1.7533^4.6
 +123     ;;989^99^SURG^NON-EXTENSIVE O.R. PROC UNRELATED TO PRINCIPAL DIAGNOSIS W/O CC/MCC^1.0425^2.2
 +124     ;;998^99^**^PRINCIPAL DIAGNOSIS INVALID AS DISCHARGE DIAGNOSIS^0.0000^0.0000
 +125     ;;999^99^**^UNGROUPABLE^0.0000^0.0000
 +126     ;;EXIT